IL17A and Graves disease: JWXYS may intervene in inflammation, immunity, apoptosis and other mechanisms to treat Graves’ disease through IL-17 signaling pathway, TNF signaling pathway, cytokine - cytokine receptor interaction and other signaling pathways.